Nathan D. Camp, Ph.D. - Publications

Affiliations: 
Pharmacology University of Washington, Seattle, Seattle, WA 
Area:
Wnt signaling

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Thomas KR, Allenspach EJ, Camp ND, Wray-Dutra MN, Khim S, Zielinska-Kwiatkowska A, Timms AE, Loftus JP, Liggitt HD, Georgopoulos K, Tasian SK, James RG, Rawlings DJ. Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice. Leukemia. PMID 34193976 DOI: 10.1038/s41375-021-01326-x  0.326
2019 Mikheeva SA, Camp ND, Huang L, Jain A, Jung SY, Avci NG, Tokita M, Wolf-Yadlin A, Zhang J, Tapscott SJ, Rostomily RC, Mikheev AM. TWIST1 Heterodimerization with E12 Requires Coordinated Protein Phosphorylation to Regulate Periostin Expression. Cancers. 11. PMID 31540485 DOI: 10.3390/Cancers11091392  0.428
2018 Köksal AS, Beck K, Cronin DR, McKenna A, Camp ND, Srivastava S, MacGilvray ME, Bodík R, Wolf-Yadlin A, Fraenkel E, Fisher J, Gitter A. Synthesizing Signaling Pathways from Temporal Phosphoproteomic Data. Cell Reports. 24: 3607-3618. PMID 30257219 DOI: 10.1016/J.Celrep.2018.08.085  0.516
2017 Sychev ZE, Hu A, DiMaio TA, Gitter A, Camp ND, Noble WS, Wolf-Yadlin A, Lagunoff M. Integrated systems biology analysis of KSHV latent infection reveals viral induction and reliance on peroxisome mediated lipid metabolism. Plos Pathogens. 13: e1006256. PMID 28257516 DOI: 10.1371/Journal.Ppat.1006256  0.387
2016 Rose JC, Huang PS, Camp ND, Ye J, Leidal AM, Goreshnik I, Trevillian BM, Dickinson MS, Cunningham-Bryant D, Debnath J, Baker D, Wolf-Yadlin A, Maly DJ. A computationally engineered RAS rheostat reveals RAS-ERK signaling dynamics. Nature Chemical Biology. PMID 27870838 DOI: 10.1038/Nchembio.2244  0.342
2016 Kountz TS, Lee KS, Aggarwal-Howarth S, Curran E, Park JM, Harris DA, Stewart A, Hendrickson J, Camp ND, Wolf-Yadlin A, Wang EH, Scott JD, Hague C. Endogenous N-terminal domain cleavage modulates α1D-adrenergic receptor pharmacodynamics. The Journal of Biological Chemistry. PMID 27382054 DOI: 10.1074/Jbc.M116.729517  0.34
2016 Camp ND, Lee KS, Cherry A, Wacker-Mhyre JL, Kountz TS, Park JM, Harris DA, Estrada M, Stewart A, Stella N, Wolf-Yadlin A, Hague C. Dynamic mass redistribution reveals diverging importance of PDZ-ligands for G protein-coupled receptor pharmacodynamics. Pharmacological Research. PMID 26773201 DOI: 10.1016/J.Phrs.2016.01.003  0.336
2015 Camp ND, Lee KS, Wacker-Mhyre JL, Kountz TS, Park JM, Harris DA, Estrada M, Stewart A, Wolf-Yadlin A, Hague C. Individual protomers of a G protein-coupled receptor dimer integrate distinct functional modules. Cell Discovery. 1. PMID 26617989 DOI: 10.1038/Celldisc.2015.11  0.358
2012 James RG, Davidson KC, Bosch KA, Biechele TL, Robin NC, Taylor RJ, Major MB, Camp ND, Fowler K, Martins TJ, Moon RT. WIKI4, a novel inhibitor of tankyrase and Wnt/ß-catenin signaling. Plos One. 7: e50457. PMID 23227175 DOI: 10.1371/Journal.Pone.0050457  0.666
2012 Camp ND, James RG, Dawson DW, Yan F, Davison JM, Houck SA, Tang X, Zheng N, Major MB, Moon RT. Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 protein. The Journal of Biological Chemistry. 287: 6539-50. PMID 22215675 DOI: 10.1074/Jbc.M111.316471  0.595
2010 Biechele TL, Camp ND, Fass DM, Kulikauskas RM, Robin NC, White BD, Taraska CM, Moore EC, Muster J, Karmacharya R, Haggarty SJ, Chien AJ, Moon RT. Chemical-genetic screen identifies riluzole as an enhancer of Wnt/β-catenin signaling in melanoma. Chemistry & Biology. 17: 1177-82. PMID 21095567 DOI: 10.1016/J.Chembiol.2010.08.012  0.632
2009 James RG, Biechele TL, Conrad WH, Camp ND, Fass DM, Major MB, Sommer K, Yi X, Roberts BS, Cleary MA, Arthur WT, MacCoss M, Rawlings DJ, Haggarty SJ, Moon RT. Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling. Science Signaling. 2: ra25. PMID 19471023 DOI: 10.1126/Scisignal.2000230  0.732
2007 Major MB, Camp ND, Berndt JD, Yi X, Goldenberg SJ, Hubbert C, Biechele TL, Gingras AC, Zheng N, Maccoss MJ, Angers S, Moon RT. Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science (New York, N.Y.). 316: 1043-6. PMID 17510365 DOI: 10.1126/Science/1141515  0.752
2007 Zhang Q, Major MB, Takanashi S, Camp ND, Nishiya N, Peters EC, Ginsberg MH, Jian X, Randazzo PA, Schultz PG, Moon RT, Ding S. Small-molecule synergist of the Wnt/beta-catenin signaling pathway. Proceedings of the National Academy of Sciences of the United States of America. 104: 7444-8. PMID 17460038 DOI: 10.1073/Pnas.0702136104  0.785
2007 Zhang Q, Major MB, Takanashi S, Camp ND, Nishiya N, Peters EC, Ginsberg MH, Jian X, Randazzo PA, Schultz PG, Moon RT, Ding S. Erratum: Small-molecule synergist of the Wnt/β-catenin signaling pathway (Proceedings of the National Academy of Sciences of the United States of America (2007) 104, 18, (7444-7448) DOI: 10.1073/pnas.0702136104) Proceedings of the National Academy of Sciences of the United States of America. 104. DOI: 10.1073/Pnas.0705165104  0.51
Show low-probability matches.